Recent Finacing
Recent Raise
Gritstone Oncology develops personalized cancer immunotherapies using a tumor-antigen identification platform (EDGE), deep-learning neoantigen prediction and delivery, with cGMP manufacturing in Pleasanton and facilities in San Francisco and Cambridge.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors